SCHEMBL3343075

SCHEMBL3343075

Cc1ccc(-n2ccc(=O)n(C)c2=O)cc1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATAD2 Q6PL18 1/20 0.46
MAPT P10636 5/20 0.44
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
ALDH1A1 P00352 6/20 0.37
CASP1 P29466 3/20 0.37
TDP1 Q9NUW8 2/20 0.37
ALOX15 P16050 1/20 0.36
HTT P42858 1/20 0.36
ATM Q13315 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
CYP3A4 P08684 3/20 0.35
TSHR P16473 2/20 0.34
GAA P10253 1/20 0.34
S100B P04271 1/20 0.33
BRPF1 P55201 1/20 0.33
MAPK14 Q16539 1/20 0.32
RAB9A P51151 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6522042 0.80 MAPT (0.43) ATAD2MAPTKDM4EMEN1KMT2A
SCHEMBL3343070 0.79 ALDH1A1 (0.38) ATAD2MAPTKDM4EMEN1KMT2A
SCHEMBL3342218 0.75 ALDH1A1 (0.54) ATAD2MAPTKDM4EMEN1KMT2A
SCHEMBL3340320 0.75 CRBN (0.51) ATAD2MAPTKDM4EMEN1KMT2A
SCHEMBL3342526 0.74 P2RX7 (0.40) ATAD2MAPTKDM4EMEN1KMT2A
SCHEMBL4965074 0.73 MAPT (0.56) ATAD2MAPTKDM4EMEN1KMT2A
SCHEMBL6524530 0.72 MAPT (0.43) ATAD2MAPTKDM4EMEN1KMT2A
SCHEMBL16371982 0.71 PKM (0.30)
SCHEMBL18856599 0.71 ALDH1A1 (0.46) ATAD2MAPTKDM4EMEN1KMT2A
SCHEMBL16364510 0.70 GSK3A (0.43) KDM4EALDH1A1ATMCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435990-B2 Dihydropyrimidone amides as P2X7 modulators ROCHE PALO ALTO LLC (US) 2013-05-07 US disclosed
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS BROTHERTON-PLEISS CHRISTINE E 2011-02-03 US disclosed
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 ATAD2 2812/4885MAPT 2598/4885KDM4E 2591/4885
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX7, P2RX3 ATAD2 2529/4885MAPT 4154/4885KDM4E 2728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.